Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Disease Foundation Announces New Members of People with Parkinson’s Advisory Council

The Parkinson’s Disease Foundation® (PDF®) is pleased to announce new members of its People with Parkinson’s Advisory Council. The council is made up of people living with Parkinson’s disease and care partners who help drive PDF’s goals of ending the disease and supporting those affected by it.

“PDF exists to meet the needs of the Parkinson’s disease community, but we can only do that if we ask for guidance from those we serve,” says PDF President Robin Elliott. “We welcome our newest advisors, knowledgeable patient leaders who have the expertise to help us more effectively improve the lives and futures of people touched by Parkinson’s disease.”

Advisory council members guide PDF’s mission and priorities; identify and solve unmet needs; provide input on programs; and serve as liaisons to the community. The advisory council has steered PDF toward its most critical programs, including its annual Community Choice Research Awards, which seek feedback from the patient community on scientific research. Additionally, its members have played a vital role in the development of educational materials to help inform their peers, including PDF’s popular Parkinson’s Disease Resource List and its educational webinars.

The advisory council’s newest members, all of whom live with Parkinson's disease, represent a wide range of communities, professional skills and personal experiences. They include the following individuals:

Julio Angulo, Ph.D., of Mesa, AZ: a retired clinical and forensic psychologist, who ran his own private practice for more than 30 years.

Girija Muralidhar, Ph.D., of Poway, CA: a retired research scientist who worked in the field of immunology for 30 years to develop new vaccines and treatments.

Daniel Novak, Ph.D., of Fort Worth, TX: an executive coach and assistant professor of business administration who spent 30 years in executive roles at IBM.

A.C. Woolnough, of Sandpoint, ID: a retired high school principal and English teacher with more than 35 years of experience in education in Alaska, Idaho and California.

Alan B. Zimmerman, of Knoxville, TN: a veteran of the US Navy, and a retired real estate broker and small business owner.

“As members of the PDF People with Parkinson’s Advisory Council, we understand more than anyone the realities of the disease and the urgency to find better treatments and a cure. We can and will work tirelessly on behalf of the one million Americans who live with Parkinson’s disease to ensure PDF’s programs meet their needs and priorities,” added Linda Morgan, M.B.A., R.Ph., of Asheville, NC, Chair of the advisory council.

Ms. Morgan remains Chair of the advisory council and a member of the PDF Board of Directors. Karen Smith, of Evansville, IN, remains Vice Chair of the advisory council.

Tuesday, May 12, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.